Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants.

MLA

Ouattara, Amed, et al. “Epitope-Based Sieve Analysis of Plasmodium Falciparum Sequences from a FMP2.1/AS02A Vaccine Trial Is Consistent with Differential Vaccine Efficacy against Immunologically Relevant AMA1 Variants.” Vaccine, vol. 38, no. 35, July 2020, pp. 5700–06. EBSCOhost, https://doi.org/10.1016/j.vaccine.2020.06.035.

APA

Ouattara, A., Niangaly, A., Adams, M., Coulibaly, D., Kone, A. K., Traore, K., Laurens, M. B., Tolo, Y., Kouriba, B., Diallo, D. A., Doumbo, O. K., Plowe, C. V., Djimdé, A., Thera, M. A., Laufer, M. K., Takala-Harrison, S., & Silva, J. C. (2020). Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants. Vaccine, 38(35), 5700–5706. https://doi.org/10.1016/j.vaccine.2020.06.035

Chicago

Ouattara, Amed, Amadou Niangaly, Matthew Adams, Drissa Coulibaly, Abdoulaye K. Kone, Karim Traore, Matthew B. Laurens, et al. 2020. “Epitope-Based Sieve Analysis of Plasmodium Falciparum Sequences from a FMP2.1/AS02A Vaccine Trial Is Consistent with Differential Vaccine Efficacy against Immunologically Relevant AMA1 Variants.” Vaccine 38 (35): 5700–5706. doi:10.1016/j.vaccine.2020.06.035.